Resolution of intracardiac and pulmonary thrombi without anticoagulation in a patient with behçet's disease: A case report

Clinical and Experimental Rheumatology

Volumn 31, Issue SUPPL.77, 2013, Pages

  Samrah, Shaher M ^a   Saadeh, Salwa S ^b   Alawneh, Kaldoon M ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b KING ABDULLAH UNIVERSITY HOSPITAL   (Jordan)

Author keywords

Beh et's disease; Cardiovascular involvement; Intraventricular thrombus; Thrombotic manifestations

Indexed keywords

AZATHIOPRINE; COLCHICINE; IMMUNOSUPPRESSIVE AGENT; LOW MOLECULAR WEIGHT HEPARIN; METHYLPREDNISOLONE; PREDNISOLONE; WARFARIN;

ADULT; ARTERY THROMBOSIS; ARTICLE; BEHCET DISEASE; CASE REPORT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC TEST; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; HEMOPTYSIS; HUMAN; INTRACARDIAC THROMBOSIS; LUNG EMBOLISM; MALE; PATHERGY TEST; PRIORITY JOURNAL; PULMONARY ARTERY THROMBUS;

ADULT; ANTICOAGULANTS; ARTERIAL OCCLUSIVE DISEASES; BEHCET SYNDROME; HEART DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PULMONARY ARTERY; THROMBOSIS; TREATMENT OUTCOME;

EID: 84884950848     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. MOGULKOC N, BURGESS MI, BISHOP PW: Intracardiac thrombus in Behçet's disease: a systematic review. Chest 2000; 118: 479-87.
2. HUONG DL DOLMAZON C, DE ZUTTERE D, WECHSLER B, GODEAU P, PIETTE JC: Complete recovery of right intraventricular thrombus and pulmonary arteritis in Behçet's disease. Br J Rheumatol 1997; 36: 130-2.
3. HATEMI G, SILMAN A, BANG et al.: EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 2008; 67: 1656- 62.
4. OWLIA MB, MEHRPOOR G: Behçet's Disease: New Concepts in Cardiovascular Involvements and Future Direction for Treatment. ISRN Pharmacol 2012; 2012: 760484.
5. GERI G, WECHSLER B, THI HUONG DU L et al.: Spectrum of cardiac lesions in Behçet disease: a series of 52 patients and review of the literature. Medicine (Baltimore) 2012; 91: 25-34.
6. SAADOUN D, ASLI B, WECHSLER B: Longterm outcome of arterial lesions in Behçet disease: a series of 101 patients. Medicine (Baltimore) 2012; 91: 18-24.
7. ERKAN F, GUL A, TASALI E: Pulmonary manifestations of Behçet's disease. Thorax 2001; 56: 572-8.
8. Criteria for diagnosis of Behçet's disease: International Study Group for Behçet's Disease. Lancet 1990; 335: 1078-80.
9. TAYER-SHIFMAN OE, SEYAHI E, NOWATZKY J, BEN-CHETRIT E et al.: Major vessel thrombosis in Behçet's disease: the dilemma of anticoagulant therapy -the approach of rheumatologists from different countries. Clin Exp Rheumatol 2012; 30: 735-40.
10. HAMURYUDAN V, OZYAZGAN Y, HIZLI N, et al.: Azathioprine in Behçet's syndrome: effects on long-term prognosis. Arthritis Rheum 1997; 40: 769-74.
11. ADLER S, BAUMGARTNER I, VILLIGER PM: Behçet's disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis. Arthritis Care Res (Hoboken) 2012; 64: 607-11.
12. ARIDA A, FRAGIADAKI K, GIAVRI E, SFIKAKIS PP et al.: Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients. Semin Arthritis Rheum 2011; 41: 61-70.